March 8, 2021
Women are taught from a young age to be ashamed of our bodies. We’re conditioned to stay small, look pretty, and have no flaws - and if we do, we must certainly never admit them. This is maybe why so many areas of women’s health - from periods to fertility to menopause - are shrouded in taboo. We’ve been taught that anything less than physical perfection is something to be ashamed of.
March 5, 2021
The 2020s are on course to become the decade of the special purpose acquisition companies (SPACs), also known as "blank check" or "shell" companies. SPACs are set to outpace IPOs once again in 2021, after a record year that saw SPACs mature from a once obscure method of going public to a rabid, flavor-of-the-month frenzy amidst both institutional and retail investors.
The year of COVID-19 saw 227...
February 26, 2021
For decades, investors, startups and a broad host of established players have viewed healthcare as ripe for innovation. However, the industry has been challenged by the momentum of the status quo – the scale, complexity, volume and ingrained practices that all need to change to wring out some much-needed efficiency.
As we were taught in physics class, the more momentum something has, the more...
February 5, 2021
Google’s $2 billion acquisition of Fitbit last month has been met with concern from privacy advocates worried about how the tech giant will use personal fitness data. This reaction prompted the tech giant to clarify that the acquisition is "about devices, not data."
The deal has brought to light a larger issue that we all seem to gloss over: Every day, millions of people publicly share seemingly...
February 5, 2021
Maternal and child health are critical for digital solutions that positively impact pregnancy outcomes. As early as 2016, this category of app saw approximately 200 million downloads as the broader consumer marketplace looked to smartphone trackers for fertility and maternity education.
While the COVID-19 pandemic has added an additional reason to have care online that avoids an in-person...
Photo by Douglas Sacha (Getty)
January 29, 2021
The alarming scale of the opioid use disorder (OUD) epidemic has resulted in unprecedented human and economic devastation, and there is significant opportunity for digital tools to alter the gold standard of care to one that is ongoing and on-demand.
The epidemic has only worsened since the onset of COVID-19, given heightened economic instability, social isolation, disruption to transportation...
January 22, 2021
Clinical trials have become big news this year amid the search for COVID-19 vaccines and treatments. They are a critical component of helping the FDA validate that new drugs and diagnostics will be both safe and effective.
Pharmaceutical companies spend over $45B a year running clinical trials, which are, by design, very methodical and measured. Unfortunately, they are also slow, unpredictable...
January 22, 2021
With the use of digital health products and services in overdrive, veteran investors and newcomers alike are lining up to fund new ventures, including those that involve the lifeblood of the healthcare industry: data.
While new investors are bullish about a digital health sector that – so far – seems to have no ceiling, those of us who were backing data companies through the 2001 recession, the...
January 8, 2021
This is not a story about COVID-19, although COVID-19 is a key catalyst. This is the story of a new healthcare ecosystem, which will allow the development of new, diverse and creative healthcare experiences.
Today I can acquire a user on Facebook, give them access to physicians via partnership with Wheel, have medicines seamlessly shipped to their homes via Truepill [Editor's note: Hogg is a...
December 23, 2020
It’s been quite a year: COVID-19, a change in administration and a year of transition for FDA digital health policy. In light of all the change and uncertainty, many digital health companies are struggling to decide upon a regulatory strategy for 2021.
My advice? If at all possible, stay away from FDA. They have enough to do right now. The people I know at FDA have been working 12- and 15-hour...